Physician

Kyla Lokitz, M.D.

According to 2025 Medicare claims, Kyla Lokitz, M.D. (NPI: 1013132653) practices internal medicine in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Caddo, LA. This provider's primary affiliated billing organization is LOUISIANA ARTHRITIS AND RHEUMATOLOGY,LLC (NPI: 1962794404; TIN: 273525208) and primary practice location at 71106-6130. Lokitz is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029) and Main Street Rural Health Poplar ACO LLC (ACO ID: A5402), participating under the MSSP model.

Lokitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 568 traditional Medicare patients, billed 16,673 HCPCS/CPT codes, and received $281,693 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,477 prescription claims across 561 beneficiaries totaling $7,098,458 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 105 records totaling $1,669. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $215,632 to $281,693. Similarly, Part D prescription costs have moved sharply higher in recent years, from $777,554 to $7,098,458. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$196K$392K2015 Medicare payment: $215,632 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $199,361 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $255,359 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $301,496 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $331,380 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $288,100 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $279,768 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $288,951 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $391,501 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $281,693 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201544114,136$215,632
201644411,516$199,361
201753416,918$255,359
201859421,868$301,496
201964121,743$331,380
202060619,927$288,100
202157517,392$279,768
202260722,206$288,951
202359137,516$391,501
202456816,673$281,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.5M$7.1M2015 Drug cost: $777,554 (USD; Tot_Drug_Cst)2016 Drug cost: $1,088,007 (USD; Tot_Drug_Cst)2017 Drug cost: $1,081,980 (USD; Tot_Drug_Cst)2018 Drug cost: $1,659,831 (USD; Tot_Drug_Cst)2019 Drug cost: $2,609,837 (USD; Tot_Drug_Cst)2020 Drug cost: $3,390,831 (USD; Tot_Drug_Cst)2021 Drug cost: $3,605,375 (USD; Tot_Drug_Cst)2022 Drug cost: $4,761,616 (USD; Tot_Drug_Cst)2023 Drug cost: $6,940,812 (USD; Tot_Drug_Cst)2024 Drug cost: $7,098,458 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153052,440$777,554
20163182,825$1,088,007
20173592,642$1,081,980
20184113,199$1,659,831
20194843,705$2,609,837
20205023,987$3,390,831
20215123,698$3,605,375
20225353,651$4,761,616
20235814,020$6,940,812
20245613,477$7,098,458

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more111111$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5081,172$86
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle60152$46
J0897Injection, denosumab, 1 mg505,400$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's498938$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab2296,440$1,677,374
Cosentyx Sensoready (2 Pens)Secukinumab1363,808$1,084,093
Enbrel MiniEtanercept1283,594$951,896
Skyrizi PenRisankizumab-Rzaa292,212$638,716
TremfyaGuselkumab351,800$493,784

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.105$1,669Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kyla Lokitz, M.D.?

Tedicare shows public-source Medicare data for Kyla Lokitz, M.D. (NPI 1013132653), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kyla Lokitz, M.D. have ACO affiliation data?

Kyla Lokitz, M.D. is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029) and Main Street Rural Health Poplar ACO LLC (MSSP, ACO ID A5402).

What billing organization is linked to Kyla Lokitz, M.D.?

Kyla Lokitz, M.D. is linked to LOUISIANA ARTHRITIS AND RHEUMATOLOGY,LLC (billing NPI 1962794404) in the available physician profile data.

Does Kyla Lokitz, M.D. have Open Payments data?

Kyla Lokitz, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.